NEWS: Thiopropazate Omeprazole Minocin Zolpidem! Chlorotrianisene Gentamicin Mirtazapine Cordarone Adenosine Bleomycin Acetazolamide Methimazole. Tolbutamide Trazodone, Cyproheptadine Nialamide: Isoniazid Inderal! Mazindol Iodamide Stavudine Methenamine Famvir Estradiol Acyclovir Suboxone Flonase Bupropion, Piperacetazine Echinacea? Percocet Hexamethonium Buspar Trichlormethiazide? Heroin Rizatriptan Amiodarone Keflex Penicillin Chlorotrianisene Loracarbef Trimethobenzamide Clomid Naloxone Advair Neomycin Clemastine Piperazine Nadolol Amaryl Zantac Cilexetil Alesse Nitroprusside! Dextrothyroxine Mephobarbital! Mepenzolate Toprol Methoxsalen Norethindrone? Lunesta Trovafloxacin Isocarboxazid Cyclizine Chlortetracycline Zyrtec! Lisinopril Lozol! Bromocriptine Methotrexate Thiabendazole Cinoxacin Ceftizoxime Phenergan Xanax Nalbuphine Ribavirin Doxepin Carphenazine Carbidopa! Skelaxin Oxymorphone! Ethionamide Concerta Provigil Ganciclovir Ethinyl Oleandomycin. Phytonadione Trihexyphenidyl Aminopterin Remeron Benzthiazide Propranolol. Tetracycline Flagyl Phenylpropanolamine Dextroamphetamine Ergotamine Climara Homatropine Gemfibrozil Methsuximide Dyphylline Aprotinin Methadone. Valerian Lotrel: Atarax Dulcolax! Trientine Terfenadine! Danazol Bumetanide Vicodin Moxifloxacin Demeclocycline Fosamax Podofilox Ketoprofen Avapro Dicyclomine! Zyrtec Clomocycline Sulindac Benztropine Brompheniramine Doxylamine Cefoperazone Lactulose? Maprotiline Iproniazid Cyclothiazide Norfloxacin Spectinomycin Isoproterenol Avodart Leflunomide! Plicamycin Dienestrol: Haldol Lorazepam Anisotropine Ritodrine: Robaxin Kaopectate Inderal Montelukast Carbimazole Nizoral Methoxamine Ambenonium Eulexin Buprenorphine Propylthiouracil Quinine Vitamin Niacinamide Iodine Anafranil Protonix Isotretinoin: Fexofenadine Epinephrine Diclofenac Nolvadex Chlordiazepoxide Oxytetracycline? Bendroflumethiazide Androgel Cephradine Bentyl Clarinex Actonel Ergocalciferol Yasmin Chlorprothixene Diphenadione: Cyclophosphamide Vaccine. Disulfiram Metolazone Cefmetazole Avapro! Methaqualone Vicodin? Cilostazol Vytorin Amrinone Heroin: Troglitazone Nicoumalone Decamethonium Calcitriol Dicumarol Leuprolide Methantheline Buspirone Acetylcholine Atacand Daunorubicin Cycloserine Pyridium Amitriptyline Mephenytoin Dianabol? Diflunisal Tinzaparin Clomiphene Isradipine Loperamide Accupril Clopidogrel Dimethindene Digoxin Phenazopyridine, Venlafaxine Zalcitabine! Sparfloxacin Risperdal Divalproex Penicillamine Butorphanol Phentolamine, Claritin Colestipol Ceforanide Cefixime. Hydrocodone Midazolam. Zyprexa Stavudine Glimepiride Brompheniramine: Dalteparin Diltiazem. Benicar Troglitazone, Oxytetracycline Repaglinide Diphenoxylate Orlistat Echinacea Penicillin. Tolmetin Timolol? Furosemide Dipyridamole Adipex Duragesic, Ursodiol Mannitol, Methazolamide Fenfluramine Menadione Aldara! Macrodantin Avodart Levaquin Dolasetron Lescol Secobarbital! Mitoxantrone Cinnarizine Beconase Erythrityl Septra Flomax Clonidine Nabumetone Oxaprozin Glipizide Dulcolax Hyperalimentation Geodon Cytomel Ceftin Hydrocortisone Dipyridamole Estrone: Glatiramer Colchicine Anagrelide Mebanazine. Famciclovir Dexfenfluramine! Pemoline Lopressor Cyclandelate Cyclothiazide Methyclothiazide Hydrochlorothiazide, Isosorbide Accutane? Cloxacillin Topamax? Lidocaine Levlen? Ranitidine Carbenicillin Fenoterol Cefonicid, Ketorolac Dibenzepin? Bromides Losec Naloxone Dobutamine Isosorbide Cilostazol! Repaglinide Elocon Dopamine Chlorthalidone Locoid Clozapine, Trichlormethiazide Dilantin Cephalothin Camphor: Heparin Terconazole Enalapril Imipramine Norflex Captopril Arthrotec Verapamil Ondansetron Pentasa, Chloroquine Felodipine Quinapril Pseudoephedrine? Methylphenidate Cafergot Zidovudine Diprolene Procainamide Hydromorphone Nafcillin Tolmetin Potassium Chlorzoxazone Mirena Cefepime Methacycline Pyrilamine Acarbose Laetrile Thalidomide Lithium! Phenolphthalein Kaolin: Metoclopramide Fastin Iprindole Methscopolamine Isradipine Glatiramer? Cefuroxime Famotidine! Thyrotropin Ethionamide Aztreonam Methyldopa: Zafirlukast Dioxyline Nicardipine Perphenazine Glycerin Pancuronium: Bontril Piperidolate! Guaifenesin Fioricet! Melphalan Chlortetracycline Mirapex Zyprexa: Meprobamate Bepridil Phenoxybenzamine Ribavirin? Chlorpropamide Cephalexin Ionamin Benadryl Hydrocortisone Nylidrin Protirelin Betamethasone Hydroflumethiazide Disulfiram. Flovent Amoxicillin! Pancuronium Pentazocine Colchicine Clonidine Phencyclidine Amiodarone? Droperidol Cefuroxime Ultracet Mesalamine Elidel Lanoxin Dicyclomine Cleocin Hyzaar Terazosin: Triamcinolone Meclizine Adapalene Troleandomycin Trifluoperazine Sucralfate Cefixime Danazol Neomycin Atracurium Oxtriphylline Carphenazine Chlorambucil Chantix Bacampicillin Levaquin! Hexamethonium Loprox Triflupromazine Esmolol Betaxolol Amiloride Viagra Methacycline Thyroid Phenyltoloxamine, Terfenadine Amoxapine Arava Ursodiol Sertraline Celecoxib Cefprozil Fenoterol Mefloquine Macrobid Thiothixene Insulin Dimethothiazine Foscarnet Tricor Ergocalciferol? Aldactone Oxyphenonium Midazolam Eprosartan Bexarotene Chloramphenicol Sumatriptan Marijuana Lodine Minocin! Elocon Naprosyn Carbidopa Cefdinir. Somatostatin Cyclobenzaprine Zuclopenthixol Cefoperazone: Nicoumalone Octreotide Indocin Paregoric Guanfacine Oxycodone? Lamivudine Thiabendazole Fluvoxamine Doxycycline Nuvaring Oxprenolol Naltrexone Gitalin Differin Pentoxifylline? Guanethidine Letrozole? Amiloride Nadroparin. Aspirin Calan Antazoline Cimetidine Afrin Voltaren Felbamate Labetalol Probenecid Meclofenamate Effexor Bricanyl! Ethinamate Oxtriphylline Procyclidine Ethynodiol, Bretylium Methotrimeprazine Chantix Daunorubicin Phenylephrine Femara Medrol Provera! Tolazamide Imdur Griseofulvin Aspirin Cosopt Prednisone? Foradil Biperiden Busulfan Tridihexethyl Minocycline Tocainide! Phenyltoloxamine Micronase Atacand Thiothixene! Phenazocine Clonazepam Simvastatin Zidovudine? Chlorothiazide Sulindac! Trimethaphan Phenelzine Cocaine Avalide, Norethindrone Beconase Rabeprazole Propofol Astemizole Cefotaxime, Reglan Alavert Olanzapine Ethambutol Soma Cortisone Toprol Methylphenidate Ticarcillin Chlorothiazide Trandolapril Isopropamide, Meloxicam Crestor Ketamine Metronidazole Minoxidil Amrinone? Methenamine Pyrazinamide Premarin Epirubicin Electricity Beclomethasone! Fluticasone Thyrotropin? Acetohexamide Novobiocin Tyropanoate Dirithromycin! Mucomyst Furazolidone Carisoprodol Imipenem. Alprazolam Thiopropazate: Plendil Hexachlorophene! Insulin Vancomycin! Ethanol Losartan. Diphemanil Somatostatin Dioxyline Ultram Eldepryl Avandia Carbachol Alteplase Zileuton Codeine Imipenem Hexoprenaline Niacinamide Divalproex? Feldene Gabapentin Quinacrine Phenprocoumon Meperidine Levitra. Ramipril Indomethacin? Estrone Parnaparin Fastin Minocycline.

Senator Alexander

Lynn Edd Story, an ETTP retiree, says: 

In Senator Alexander’s response to the letter Dave Reichle, President of CORRE, presented to him at the meeting in Farragut, Senator Alexander said:

 “that the principal problem is that there is a difference in opinion over whether there is sufficient surplus to grant the requests of CORRE on behalf of retirees.”  

In the letter, CORRE estimates that the surplus for the multi-employer pension plan is now approximately $800 million, about 135% of actuarial requirement. CORRE also estimates the benefits we are requesting would cost about $200 million. To me, it seems like the two sides are working from two different sets of information.

 

Is there information available that shows how CORRE got their information? Do the people, that we are requesting the funds from, have the same information available to them? If not already done, would it be helpful to share this information with Senator Alexander, and others?

7 Responses to “Senator Alexander”

  1. Al Brooks Says:

    I beg to differ with Senator Alexander but the principal problem is not the size of the surplus relative to the cost of the CORRE proposal. DOE can make additions to the trust fund any time congress budgets the funds. The difference of opinion lies in whether a federal agency should permit a retiree’s pension to decrease in buying power as the years go by. I never recall anyone promising me a pension which would decrease in value with inflation.

    It is not reasonable for DOE to assume they must never add funding to the pension trust fund; changing times require corresponding actions. Nor should one assume they have discharged a responsibility by neglecting to meet it.

    If a one payment trust fund were possible, I could have stopped paying into my “old age benefits” fund after the first penny in 1936.

    Al Brooks

  2. admin Says:

    CORRE gets its information on the MEPP fund, including how much the surplus is, from BWXT, the company that is contracted by DOE to manage the multi-employer pension plan (MEPP). BWXT hires an actuarial firm to actually perform the accounting. So, CORRE’s number comes from actuary for the fund, and the information is solid—no question about that.

    Where the difference arises, probably, is in whether there is sufficient surplus to grant adjustments. CORRE and DOE have very different points of view about that. So, undoubtedly, when the Senator asks DOE whether there is sufficient surplus, DOE and the contractors say “No!). They are wrong, of course.

    DOE is simply following a policy of never granting adjustments and always attempts to justify that position—whatever it takes. And, that is why they tell Congressman the surplus is insufficient. The fund is managed in such a way that the surplus is always too big for them to have to put any money into the plan (none since 1984) and too small (in DOE view) to allow adjustments. Of course, CORRE does all it can to expose this dissembling by DOE. It is in the interest of the contractors to follow DOE lead on this- they cannot easily do otherwise, as they are beholden to DOE for their fee and contract.

  3. Nancy Owens Says:

    Some of the confusion regarding:

    “that the principal problem is that there is a difference in opinion over whether there is sufficient surplus to grant the requests of CORRE on behalf of retirees.”

    probably stems from the Pension Protection Act that becomes effective 1/1/2008 and the Cost Accounting Standards “harmonization” and resulting implications. The gist of the issue is covered in this news item from AIA:

    Pension Protection Act Impacting Cash Flow

    Many AIA members will face a sharp increase in the cost of financing defined benefit pension plans as early as January 2008 as a result of the Pension Protection Act (PPA) signed by President Bush in August 2006.

    The PPA reduces interest rate assumptions in computing present value of benefits, shortens periods for amortizing unfunded liabilities, and establishes a funding target of 100 percent of liabilities. The changes are effective January 1, 2008, for all but a limited number of eligible contractors who were granted exemptions until 201l.

    In addition, contractors required to comply with the government’s Cost Accounting Standards (CAS) will face a cash flow burden that other U.S. companies will not. The aggressive pension funding required by the PPA will create a major cash flow imbalance due to a gap between when contractors must begin increased pension contributions and when the contributions can be recognized as pension costs under the current CAS regulations.

    The increased funding associated with meeting the PPA requirements won’t be recognized immediately as costs under government contracts because the current CAS mandates higher interest rate assumptions and longer amortization periods. Initial estimates conclude that the difference between current CAS and PPA pension measurements for all government contractors will be measured in billions of dollars of increased net contractor cash outflow.

    With the PPA, Congress attempted to address the cash flow problem by requiring the harmonization of CAS 412 and 413, the pension standards, with the minimum funding requirements of PPA. The target date for harmonization, however, is January 2010, two years after the date most contractors must begin meeting the PPA funding requirements.

    Options for correcting the cash flow inequity before harmonization are limited. One is to request that DoD and GSA ask the CAS Board to grant a temporary waiver to CAS 412 to allow contractors to include in their forward pricing rates a factor for the estimated impact of the differences in the PPA and CAS requirements. The amount included in contract prices could be identified precisely and be subjected to adjustment after the actual impact to contract prices is known.

    The other option is to request the congressional sponsors of the PPA to amend the act to delay the date for compliance with the funding requirement for all government contractors until January 1, 2011, consistent with the date that the CAS Board must complete harmonization of the PPA and CAS.

    A decision on the best approach was expected in early September.

    AIA Source: dick.powers@aia-aerospace.org

    This link also provides some useful information:

    http://www.ifebp.org/Resources/News/Regulatory+Updates/CASB.htm

    Some very interesting public comments on harmonizing CAS 412 & 413 with the PPA:

    http://www.whitehouse.gov/omb/procurement/casb/public_comments_case_20 07-02s.pdf

    It appears that pension funding, whether there’s an apparent surplus or not - is a very hot topic. This may be part of the confusion and another challenge for CORRE.

  4. Nancy Owens Says:

    Check out DOE’s accured FY 06 unfunded pension & medical liability of $11.9B (slide 5) and decide for yourself if you think DOE has a problem:

    http://www.management.energy.gov/PENSIONMEDICALBENEFITSMARCH2007.pdf

    This is the “guidance” DOE has issued:

    http://management.energy.gov/policy_guidance/1348.htm

  5. admin Says:

    DOE has a problem, but it is problem of its own creation. Regarding unfunded liability, most of it is medical costs– not pensions that are unfunded. DOE has not contributed to the MEPP fund in 24 years, thus the surplus has been managed to avoid paying into the fund. The funding requirements does represent more of a challenge to CORRE, but even more for DOE. DOE practice of adding the medical and pension costs together to talk about unfunded liabilities leads to great confusion and allows misrepresentation of the obligations that DOE has. It has an obligation to fund medical costs every year. The out years they are counting as unfunded obligations. How is that so?

    For more on DOE misinformation, including this issue, go to the CORRE website at this page:

    http://www.corre.info/Features/rebuttal_disinfo.htm

  6. Nancy Owens Says:

    Check out Goal 3 to see how DOE plans to eliminate Pinellas & Fluor Fernald pension liabilities - what are the implications for the K-25 Site?

    http://www.gjo.doe.gov/documents/message/lmgoals.pdf

  7. Nancy Owens Says:

    According to the DOE Office of Legacy Managment’s 2007 Strategic Plan, they are responsible for:

    Legacy Management -

    An office of DOE that was
    created in 2003 to manage the long-term responsibilities
    of closed sites, especially the sites selected
    for Accelerated Cleanup. The long-term responsibilities
    include long-term surveillance and maintenance as
    well as physical management of the site. Conditions
    sometimes permit compatible reuse of the site. Longterm
    responsibilities also include managing site records
    and electronic information, overseeing the pension and
    benefit programs for retired contractor personnel, and
    responding to stakeholder inquiries.

    Are they responding to stakeholder inquiries??

    Another quote from their Strategic Plan that I found interesting is:

    The liability for unfunded post-closure benefits
    (for Fernald, Grand Junction, Mound, Pinellas,
    Rocky Flats, and the gaseous diffusion plants
    in Ohio and Kentucky) includes payments for
    unfunded pension benefits and retiree health
    and life insurance. The liability will probably not
    be fully settled for decades. Legacy Management
    will develop a plan to facilitate the consistent
    and comprehensive payout of medical and
    pension benefits at all closure facilities. Legacy
    Management will create sound policy and guidance
    to adequately and efficiently fulfill the Department’s
    obligations to its contractor work force.

    I’d say they’ve got their work cut out for them, but it looks like they’ve got some plans for eliminating Pinellas and Fernald pension liabilities.

    http://www.gjo.doe.gov/documents/3_pro_doc/1_strategic_plan/strat_plan 200705.pdf

Leave a Reply

You must be logged in to post a comment.